Modification in body weight associated with antiepileptic drugs

Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.

Saved in:
Bibliographic Details
Main Authors: Gaspari,Camilla N. De, Guerreiro,Carlos A.M.
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-282X2010000200024
record_format ojs
spelling oai:scielo:S0004-282X20100002000242010-04-28Modification in body weight associated with antiepileptic drugsGaspari,Camilla N. DeGuerreiro,Carlos A.M. epilepsy antiepileptic drugs dietary habits body weight Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia - ABNEUROArquivos de Neuro-Psiquiatria v.68 n.2 20102010-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024en10.1590/S0004-282X2010000200024
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Gaspari,Camilla N. De
Guerreiro,Carlos A.M.
spellingShingle Gaspari,Camilla N. De
Guerreiro,Carlos A.M.
Modification in body weight associated with antiepileptic drugs
author_facet Gaspari,Camilla N. De
Guerreiro,Carlos A.M.
author_sort Gaspari,Camilla N. De
title Modification in body weight associated with antiepileptic drugs
title_short Modification in body weight associated with antiepileptic drugs
title_full Modification in body weight associated with antiepileptic drugs
title_fullStr Modification in body weight associated with antiepileptic drugs
title_full_unstemmed Modification in body weight associated with antiepileptic drugs
title_sort modification in body weight associated with antiepileptic drugs
description Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.
publisher Academia Brasileira de Neurologia - ABNEURO
publishDate 2010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024
work_keys_str_mv AT gasparicamillande modificationinbodyweightassociatedwithantiepilepticdrugs
AT guerreirocarlosam modificationinbodyweightassociatedwithantiepilepticdrugs
_version_ 1756374480187293696